Rolf Barth to Diabetes Mellitus, Type 1
This is a "connection" page, showing publications Rolf Barth has written about Diabetes Mellitus, Type 1.
Connection Strength
0.509
-
207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Transplantation. 2021 12 01; 105(12 Suppl 1):S3.
Score: 0.140
-
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States. Am J Transplant. 2021 07; 21(7):2620-2622.
Score: 0.133
-
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375.
Score: 0.132
-
Nasogastric decompression is not necessary after simultaneous pancreas-kidney transplantation. Ann Surg. 2008 Feb; 247(2):350-6.
Score: 0.053
-
Vascularized islet cell transplantation in miniature Swine: islet-kidney allografts correct the diabetic hyperglycemia induced by total pancreatectomy. Diabetes. 2002 Nov; 51(11):3220-8.
Score: 0.037
-
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Clin Transpl. 2009; 461-3.
Score: 0.014